Eltroxin New Formulation 25. 50. 75. 88. 100. 112. 125. 137. 150. 175. 200ug Tablets
PDF Leaflet Revision Date: 30 June 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of untreated hypothyroidism.
Dosage (summary)
Adults: 50-100 u03bcg daily, adjust by 50 u03bcg every 4-6 weeks. Elderly: Start with 25-50 u03bcg.
Special Populations
- Elderly
- Children
- Patients with cardiac disease
Pregnancy & Breastfeeding
Category A; dosage may need adjustment during pregnancy; monitor TSH.
Key Drug Interactions
- Anticoagulants
- Diabetes medications
- Antidepressants
- Anticonvulsants
Contraindications
- Hypersensitivity to levothyroxine
- Untreated hyperthyroidism
- Adrenal insufficiency
Common side effects
- Hyperthyroidism
- Palpitations
- Weight loss
- Insomnia
- Hair loss
Counselling Points
- Take on an empty stomach
- Do not double doses if missed
- Regular monitoring of thyroid function
Serious warnings
- Risk of angina and myocardial infarction
- Thyroid storm in overdose
Important Disclaimer
The Eltroxin New Formulation 25. 50. 75. 88. 100. 112. 125. 137. 150. 175. 200ug Tablets professional information leaflet below is the property of Pharmacare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
